Who are 0.45%NaCl's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): sodium bicarbonate Ringer's solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/0-45-nacl.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

0.45%NaCl — Competitive Intelligence Brief

0.45%NaCl (0.45%NaCl) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intravenous fluid / Electrolyte solution. Area: Supportive Care / Fluid Management.

phase 3 Intravenous fluid / Electrolyte solution Supportive Care / Fluid Management Small molecule Live · refreshed every 30 min

Target snapshot

0.45%NaCl (0.45%NaCl) — Hamilton Health Sciences Corporation. 0.45% sodium chloride solution provides isotonic fluid replacement to maintain electrolyte balance and hydration.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
0.45%NaCl TARGET	0.45%NaCl	Hamilton Health Sciences Corporation	phase 3	Intravenous fluid / Electrolyte solution
sodium bicarbonate Ringer's solution	sodium bicarbonate Ringer's solution	The First Affiliated Hospital with Nanjing Medical University	marketed	Crystalloid intravenous fluid / electrolyte solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intravenous fluid / Electrolyte solution class)

Hamilton Health Sciences Corporation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). 0.45%NaCl — Competitive Intelligence Brief. https://druglandscape.com/ci/0-45-nacl. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab